Dr Agarwal’s Eye Hospital Merges with Dr Agarwal’s Health Care

Dr Agarwal’s Eye Hospital Merges with Dr Agarwal’s Health Care to Unify Corporate Structure

Dr Agarwal’s Eye Hospital Merges with Dr Agarwal’s Health Care to Unify Corporate Structure

The consolidation is expected to simplify governance, streamline capital allocation and align investments in hospitals, clinical capabilities, technology and talent across the group.

Dr Agarwal’s Health Care (AHCL) has completed the amalgamation of Dr Agarwal’s Eye Hospital (AEHL), bringing both entities under a single corporate structure effective November 1, 2026.

The consolidation is expected to simplify governance, streamline capital allocation and align investments in hospitals, clinical capabilities, technology and talent across the group.

“The amalgamation is an important step in simplifying our corporate structure and bringing the business together under one listed platform,” Adil Agarwal, CEO of Dr Agarwal’s Health Care, said.

The merger follows approval from the National Company Law Tribunal (NCLT), Chennai Bench, through an order dated September 30, 2026. AHCL said the necessary conditions under the scheme had been fulfilled, with the order filed with the Registrar of Companies on October 14, 2026.

Dr Agarwal’s Eye Hospital had announced its board’s approval of the merger with its listed parent in August 2025. At the time, AHCL held a 71.90% stake in AEHL.

Under the approved arrangement, eligible shareholders of Dr Agarwal’s Eye Hospital will receive 23 fully paid-up equity shares of Dr Agarwal’s Health Care, with a face value of INR 1 each, for every two fully paid-up AEHL shares with a face value of INR 10 each. This translates to 11.5 AHCL shares for every AEHL share held.

The AHCL board has fixed November 18, 2026, as the record date for determining the shareholders eligible to receive the consideration shares under the scheme.

The merger has also changed the combined entity’s authorised share capital, which has increased from INR 90 Cr to INR 110 Cr. The increase reflects the consolidation of the two companies’ equity capital, while the authorised preference share capital remains unchanged at INR 35.80 Cr.

Following the scheme’s effectiveness, Dr Agarwal’s Eye Hospital will stand dissolved without being wound up, and its board will cease to exist under the terms of the arrangement. Its status will be updated to “Amalgamated” in the records of the Registrar of Companies.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Welcome back.

Pick up where you left off on Digital Health News.

Sign in to DHN

For existing DHN and DHN Plus members.

or
Continue with Google
New to DHN?